PIK3CA mutations can initiate pancreatic tumorigenesis and are targetable with PI3K inhibitorsSusan N. Payne(University of Wisconsin Carbone Cancer Center), Dustin A. Deming(University of Wisconsin–Madison)OncogenesisOctober 5, 201510.1038/oncsis.2015.28Cited by 75SaveCiteExport RISWatch citationsRelated PapersmTOR Inhibition Elicits a Dramatic Response in PI3K-Dependent Colon Cancers|PLoS ONE|2013|22Colon Cancer Tumorigenesis Initiated by the H1047R Mutant PI3K|PLoS ONE|2016|22Cancer-Associated Fibroblast Proteins as Potential Targets against Colorectal Cancers|Cancers|2024|14